Weinbaum CM, Williams I., Mast, EE, et al, Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep.2008;57(RR08);1-20.
2.
Dienstag JLHepatitis B virus infection. N Engl J Med.2008;359(14):1468-500.
3.
Choudhury J. , Sanyal AJClinical aspects of fatty liver disease. Semin Liver Dis. 2004;24(4):349-362.
4.
Athyros VG, Mikhailidis DP, Didangelos TP, et al. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin. 2006;22(5):873-883.
5.
Georgescu EF , Georgescu M.Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. J Gastrointestin Liver Dis. 2007;16(1):39-46.
